Jazz Pharmaceuticals (JAZZ) Change in Inventory (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Change in Inventory of $77.8 million for Q1 2026, up 118.54% year-over-year from $35.6 million in Q1 2025, and up 1107.77% quarter-over-quarter from -$7.7 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Change in Inventory (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Change in Inventory history runs 17 years deep, the most recent figure standing at $77.8 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 118.54% year-over-year to $77.8 million; the TTM figure through Mar 2026 stood at $128.2 million (up 87.77% YoY), while the FY2025 annual figure was $86.0 million, up 88.93% from the prior year.
- Change in Inventory for Q1 2026 stood at $77.8 million, up from -$7.7 million in the prior quarter.
- The five-year high for Change in Inventory was $77.8 million in Q1 2026, with the low at -$7.7 million in Q4 2025.
- The 5-year median for Change in Inventory is $9.3 million (2024), against an average of $16.0 million.
- The sharpest annual moves came in 2024 and 2025: Change in Inventory surged 1229.42% in 2024, then tumbled 141.36% in 2025.
- Jazz Pharmaceuticals' Change in Inventory stood at -$816000.0 in 2022, then surged by 272.06% to $1.4 million in 2023, then soared by 1229.42% to $18.7 million in 2024, then slumped by 141.36% to -$7.7 million in 2025, then soared by 1107.77% to $77.8 million in 2026.
- Business Quant data shows JAZZ's Change in Inventory at $77.8 million in Q1 2026, -$7.7 million in Q4 2025, and $31.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 29.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.90 Mn |
| Jun 30, 2026 | 29.90 Mn |
| Mar 31, 2026 | 77.80 Mn |
| Mar 31, 2026 | 77.80 Mn |
| Dec 31, 2025 | -7.72 Mn |
| Dec 31, 2025 | -7.72 Mn |
| Sep 30, 2025 | 31.91 Mn |
| Sep 30, 2025 | 31.91 Mn |
| Jun 30, 2025 | 26.25 Mn |
| Jun 30, 2025 | 26.25 Mn |
| Mar 31, 2025 | 35.60 Mn |
| Mar 31, 2025 | 35.60 Mn |
| Dec 31, 2024 | 18.67 Mn |
| Dec 31, 2024 | 18.67 Mn |
| Sep 30, 2024 | 9.29 Mn |
| Sep 30, 2024 | 9.29 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Mar 31, 2024 | 12.84 Mn |
| Mar 31, 2024 | 12.84 Mn |